Latest Insider Transactions at Becton Dickinson & CO (BDX)
This section provides a real-time view of insider transactions for Becton Dickinson & CO (BDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BECTON DICKINSON & CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BECTON DICKINSON & CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2025
|
Bertram L Scott Director |
SELL
Open market or private sale
|
Direct |
700
-1.91%
|
$158,900
$227.99 P/Share
|
|
Feb 10
2025
|
Jeffrey William Henderson Director |
BUY
Open market or private purchase
|
Direct |
1,500
+15.76%
|
$349,500
$233.62 P/Share
|
|
Jan 28
2025
|
William M Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+21.06%
|
-
|
|
Jan 28
2025
|
Catherine M Burzik Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+6.12%
|
-
|
|
Jan 28
2025
|
Christopher Ian Montague Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+3.94%
|
-
|
|
Jan 28
2025
|
Jeffrey William Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+12.49%
|
-
|
|
Jan 28
2025
|
Claire Fraser Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+3.73%
|
-
|
|
Jan 28
2025
|
Carrie L Byington Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+19.52%
|
-
|
|
Jan 28
2025
|
R Andrew Eckert Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+9.21%
|
-
|
|
Jan 28
2025
|
Bertram L Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+2.47%
|
-
|
|
Jan 28
2025
|
Timothy M Ring Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+1.58%
|
-
|
|
Jan 28
2025
|
Joanne Waldstreicher Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+29.06%
|
-
|
|
Jan 21
2025
|
Shana Carol Neal EVP and Chief People Officer |
SELL
Open market or private sale
|
Direct |
787
-4.86%
|
$188,880
$240.0 P/Share
|
|
Jan 21
2025
|
David Shan EVP and Chief ISC Officer |
SELL
Open market or private sale
|
Direct |
500
-8.01%
|
$120,000
$240.0 P/Share
|
|
Jan 17
2025
|
Michael David Garrison EVP & President, Medical |
SELL
Open market or private sale
|
Direct |
597
-9.72%
|
$140,892
$236.51 P/Share
|
|
Jan 07
2025
|
Shana Carol Neal EVP and Chief People Officer |
SELL
Open market or private sale
|
Direct |
788
-4.64%
|
$185,180
$235.0 P/Share
|
|
Jan 03
2025
|
David Shan EVP and Chief ISC Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
44
-0.7%
|
-
|
|
Dec 19
2024
|
Michael David Garrison EVP & President, Medical |
SELL
Open market or private sale
|
Direct |
2,838
-31.61%
|
$632,874
$223.33 P/Share
|
|
Dec 09
2024
|
Roland Goette EVP and President, EMEA |
SELL
Open market or private sale
|
Direct |
638
-4.29%
|
$139,722
$219.03 P/Share
|
|
Dec 06
2024
|
Roland Goette EVP and President, EMEA |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,490
-38.98%
|
$2,097,290
$221.01 P/Share
|
|
Dec 06
2024
|
Roland Goette EVP and President, EMEA |
SELL
Open market or private sale
|
Direct |
4,483
-15.55%
|
$990,743
$221.01 P/Share
|
|
Dec 06
2024
|
Roland Goette EVP and President, EMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
13,334
+20.88%
|
$2,093,438
$157.79 P/Share
|
|
Dec 06
2024
|
Shana Carol Neal EVP and Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,000
-5.56%
|
$220,000
$220.49 P/Share
|
|
Dec 05
2024
|
David Shan EVP and Chief ISC Officer |
SELL
Open market or private sale
|
Direct |
1,500
-19.27%
|
$330,000
$220.25 P/Share
|
|
Nov 26
2024
|
Pavan Kumar Mocherla EVP & President Greater Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
20
-0.7%
|
-
|
|
Nov 26
2024
|
Pavan Kumar Mocherla EVP & President Greater Asia |
BUY
Grant, award, or other acquisition
|
Direct |
1,055
+15.21%
|
-
|
|
Nov 26
2024
|
Michelle Quinn EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
376
-5.15%
|
-
|
|
Nov 26
2024
|
Michelle Quinn EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,348
+13.65%
|
-
|
|
Nov 26
2024
|
Shana Carol Neal EVP and Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
509
-2.75%
|
-
|
|
Nov 26
2024
|
Shana Carol Neal EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,109
+10.23%
|
-
|
|
Nov 26
2024
|
Michael Feld EVP & President, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
2,553
+21.74%
|
-
|
|
Nov 26
2024
|
Antoine C Ezell EVP, President Americas & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,357
-10.18%
|
-
|
|
Nov 26
2024
|
Antoine C Ezell EVP, President Americas & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
4,007
+13.95%
|
-
|
|
Nov 26
2024
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,192
-19.45%
|
-
|
|
Nov 26
2024
|
Christopher Del Orefice EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,899
+23.45%
|
-
|
|
Nov 26
2024
|
Richard Byrd EVP & President Interventional |
SELL
Payment of exercise price or tax liability
|
Direct |
1,204
-11.41%
|
-
|
|
Nov 26
2024
|
Richard Byrd EVP & President Interventional |
BUY
Grant, award, or other acquisition
|
Direct |
4,495
+19.44%
|
-
|
|
Nov 26
2024
|
Thomas E Polen Jr Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
23,564
-19.01%
|
-
|
|
Nov 26
2024
|
Thomas E Polen Jr Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
52,124
+18.95%
|
-
|
|
Nov 26
2024
|
David Shan EVP and Chief ISC Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
124
-1.57%
|
-
|
|
Nov 26
2024
|
David Shan EVP and Chief ISC Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,216
+13.15%
|
-
|
|
Nov 26
2024
|
Roland Goette EVP and President, EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
196
-1.25%
|
-
|
|
Nov 26
2024
|
Roland Goette EVP and President, EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
3,105
+9.31%
|
-
|
|
Nov 26
2024
|
Michael David Garrison EVP & President, Medical |
SELL
Payment of exercise price or tax liability
|
Direct |
1,230
-12.05%
|
-
|
|
Nov 26
2024
|
Michael David Garrison EVP & President, Medical |
BUY
Grant, award, or other acquisition
|
Direct |
4,828
+21.28%
|
-
|
|
Nov 21
2024
|
Shana Carol Neal EVP and Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.19%
|
-
|
|
Nov 21
2024
|
Shana Carol Neal EVP and Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
111
+0.65%
|
-
|
|
Sep 07
2024
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-3.51%
|
-
|
|
Sep 01
2024
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
254
-1.88%
|
-
|
|
Sep 01
2024
|
Richard Byrd EVP & President Interventional |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-3.44%
|
-
|